Document is current
Any future updates will be listed below
-
Authors
Blumling, Amy A.
McGowan, Michelle L.
Prows, Cynthia A.
Childers-Buschle, Kristin
Martin, Lisa J.
Lynch, John A.
Dufendach, Kevin R.
Lipstein, Ellen A.
Kovacic, Melinda Butsch
Brinkman, William B.
Myers, Melanie F.
-
Funding
Funding for this research was provided by:
National Human Genome Research Institute (1R01HG010166-01A1, 1R01HG010166-01A1, 1R01HG010166-01A1, 1R01HG010166-01A1, 1R01HG010166-01A1, 1R01HG010166-01A1, 1R01HG010166-01A1, 1R01HG010166-01A1, 1R01HG010166-01A1, 1R01HG010166-01A1, 1R01HG010166-01A1)
University of Cincinnati (UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425)
Cincinnati Children’s Hospital Medical Center (UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425, UL1TR001425)
- License Information
-
More Information
Article History
Received: 26 June 2023
Accepted: 25 November 2024
First Online: 18 December 2024
Declarations
:
: The Cincinnati Children’s Hospital Medical Center Institutional Review Board has approved this study, IRB 2020 − 0517 Engaging adolescents in decisions about genomic results. Informed consent or assent will be obtained from all participants and/or their legal guardian(s)/parent(s) before the start of the study. All procedures will be carried out in accordance with the relevant guidelines, e.g., Declaration of Helsinki.
: Not applicable.
: Dr. William Brinkman has common stock holdings in the following publicly traded companies: Pfizer, Merck, Abbott Laboratories, Viatris, and Johnson & Johnson. No additional authors declare any competing interests.
